Henatinib
- Generic Name
- Henatinib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C25H29FN4O4
- CAS Number
- 1239269-51-2
- Unique Ingredient Identifier
- TE20GB753F
- Background
Henatinib has been used in trials studying the treatment of Advanced Solid Cancer.
- Associated Conditions
- -
- Associated Therapies
- -
A Phase I Study of Henatinib in Patients With Advanced Solid Malignancies
- First Posted Date
- 2011-08-15
- Last Posted Date
- 2012-12-21
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 44
- Registration Number
- NCT01416623
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath